MedTrace Logo

Strength Training Adaptations, Age and Genes

NCT02589990 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2018-09-28

No results posted yet for this study

Summary

The study investigates the effect of maximal strength training on muscular strength and power in different age groups from 20 to 80 year old. It also relates the training adaptations to different known genes such as angiotensin I-converting enzyme (ACE) and Alpha-actinin-3 (ACTN3). Participants will complete an eight weeks, three times per week training intervention of maximal strength training with a pre-post design. In addition, blood samples will be collected for the analyses of genetic variances.

Conditions

  • Healthy

Interventions

BEHAVIORAL

Strength training

see arm description

Sponsors & Collaborators

  • Norwegian University of Science and Technology

    collaborator OTHER

  • University of South-Eastern Norway

    lead OTHER

Principal Investigators

  • Øyvind Støren, PhD · University of South-Eastern Norway

  • Mona Sæbø, PhD · University of South-Eastern Norway

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2018-08-31
Completion
2018-09-03

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02589990 on ClinicalTrials.gov